Published in Cancer Weekly, November 22nd, 1999
Luc R.H.M Schurmans and colleagues from Leiden University Medical Center, The Netherlands, and Loyola University of Chicago, Illinois, USA, sought to establish to what extent immune privilege interferes with T-cell-mediated antitumor immunotherapy.
They established a new ocular tumor model in the mouse and tested whether well-defined tumor-specific CTLs could eradicate an immunogenic intraocularly growing tumor ("Successful Immunotherapy of an Intraocular Tumor...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.